FITC anti-mouse Ly-6G Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Ly-6G transfected EL-4J cell line.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.

Concentration

0.5 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 10⁶ cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser

Blue Laser (488 nm)

Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C¹⁵. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A8¹⁵. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.4¹⁶.

Additional reported applications (for the relevant formats) include: immunohistochemistry⁹ of frozen sections¹⁰ and paraffin-embedded sections¹¹, depletion^{4, 12-14}, and spatial biology (IBEX)^20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
3. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
4. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
5. Valladao A, et al. 2016. J Immunol. 197(12):4541-4551. PubMed
6. Campbell IK, Leong D 2016. J Immunol. 197(11):4392-4402. PubMed
7. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
8. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
9. He R, et al. 2021. J Immunol. 206:2353. PubMed
10. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
11. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
12. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
13. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
14. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
15. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
16. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
17. Long M, et al. 2017. J Immunol. 198(2):862-872. PubMed
18. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
19. Mandraju R, et al. 2014. J Immunol. 192:4303. PubMed
20. Patsalos A, et al. 2019. J Immunol. 203:1532. PubMed
21. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
22. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
23. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
24. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
25. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
26. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
27. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
28. Huai W, et al. 2019. J Exp Med. 216:772. PubMed
29. Han J, et al. 2022. FEBS J. 289:417. PubMed
30. Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
31. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
32. Torre S, et al. 2016. Nat Immunol. 10.1038/ni.3581. PubMed
33. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
34. Wang C, et al. 2015. Sci Rep. 5: 14124. PubMed
35. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
36. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
37. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
38. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
39. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
40. Castiglioni A, et al. 2015. PLoS One. 10:128094. PubMed
41. Guesdon W, et al. 2015. J Infect Dis. 212: 1332 - 1340. PubMed
42. Strother R, et al. 2016. J Immunol. 197(11):4301-4311. PubMed
43. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
44. Ueki H, et al. 2020. Nat Protoc. 15:1041. PubMed
45. Saika A, et al. 2020. FASEB Bioadv. 2:59. PubMed
46. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
47. Wang H et al. 2017. Developmental cell. 40(6):566-582 . PubMed
48. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
49. Billi AC, et al. 2019. JCI Insight. 4:8. PubMed
50. Han YH, et al. 2021. Science. 373:. PubMed
51. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
52. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
53. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
54. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
55. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
56. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
57. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
58. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
59. Wu X, et al. 2021. Elife. 10:. PubMed
60. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
61. Abad C, et al. 2014. J Leukoc Biol. 95:357. PubMed
62. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
63. Liu Z, et al. 2016. J Biol Chem. 291: 1441 - 1447. PubMed
64. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
65. Na YR, et al. 2020. Cell Rep. 107643:31. PubMed
66. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
67. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
68. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
69. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
70. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
71. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
72. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
73. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
74. Jacome-Galarza C, et al. 2011. J Bone Miner Res. 26:1207. PubMed
75. Huixin Xu et al. 2018. EMBO molecular medicine. 10(9) pii: e8931. PubMed
76. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
77. Geng S, et al. 2021. JCI Insight. 6:. PubMed
78. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
79. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
80. Chen M, et al. 2021. Oncol Lett. 21:435. PubMed
81. Minogue A, et al. 2014. Neurobiol Aging. 35:1442. PubMed
82. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
83. Zheng J, et al. 2020. bioRxiv. . PubMed
84. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
85. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
86. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
87. Roy K, et al. 2019. Immunity. 50:616. PubMed
88. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
89. Christ A, et al. 2018. Cell. 172:162. PubMed
90. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
91. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
92. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
93. Gousopoulos E, et al. 2016. Am J Pathol. 186:2193-2203. PubMed
94. Radjabova V, et al. 2015. J Immunol. 195: 3149 - 3159. PubMed
95. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
96. He J, et al. 2019. J Clin Invest. 130. PubMed
97. Yu L, et al. 2019. Elife. 8:e46677. PubMed
98. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
99. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
100. Flögel U, et al. 2021. Nat Commun. 12:5847. PubMed
101. Wu M, et al. 2013. Proc Natl Acad Sci U S A. 110:9439. PubMed
102. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
103. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
104. Shih Y, et al. 2015. JPEN J Parenter Enteral Nutr. . PubMed
105. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
106. Fischer KJ, et al. 2019. J Immunol. 202:2027. PubMed
107. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
108. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
109. Uderhardt S, et al. 2019. Cell. 177:541. PubMed
110. Hermetet F, et al. 2019. Nat Commun. 10:523. PubMed
111. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
112. Shevchenko MA, et al. 2018. J Immunol Res. 8:53. PubMed
113. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
114. Zheng J, et al. 2020. Nature. . PubMed
115. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
116. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
117. Rebecca S Dickinson et al. 2017. Wellcome open research. 0.155555556 . PubMed
118. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
119. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
120. Simpson K, et al. 2012. J Immunol. 189:5533. PubMed
121. Giampazolias E, et al. 2021. Cell. . PubMed
122. Prizant H, et al. 2021. Cell Reports. 36:109523. PubMed
123. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
124. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
125. Li YT, et al. 2019. Elife. 8:e47642. PubMed
126. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
127. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
128. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
129. Qin W, et al. 2022. Bio Protoc. 12:e4287. PubMed
130. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
131. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
132. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
133. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
134. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
135. Thomas DG et al. 2018. Cell reports. 25(13):3774-3785 . PubMed
136. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
137. Chen ST et al. 2019. Cell host & microbe. 25(4):602-616 . PubMed
138. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
139. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
140. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
141. Makino A, et al. 2021. iScience. 24:103201. PubMed
142. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
143. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
144. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
145. Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed
146. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
147. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
148. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
149. van Geffen C, et al. 2021. Front Immunol. 12:695933. PubMed
150. Gu H, et al. 2021. Elife. 10:. PubMed
151. Issah Y, et al. 2021. Elife. 10:. PubMed
152. Wei Y, et al. 2021. Endocrinology. 162(8):. PubMed
153. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
154. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
155. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
156. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
157. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
158. Danzer H, et al. 2020. Elife. 9:00. PubMed
159. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
160. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
161. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
162. Smith LK, et al. 2021. Elife. 10:. PubMed
163. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
164. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
165. Chen J, et al. 2014. Cell Res. 24:1050. PubMed
166. Xu Y, et al. 2014. Proc Natl Acad Sci U S A. 111:6371. PubMed
167. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
168. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
169. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
170. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
171. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
172. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
173. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
174. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
175. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
176. Zhang H, et al. 2022. Commun Biol. 5:916. PubMed
177. Stadtmann A, et al. 2015. J Immunol. 195: 1152-1161. PubMed
178. Jia H, et al. 2016. J Immunol. 197: 859 - 871. PubMed
179. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
180. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
181. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
182. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
183. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
184. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
185. Chuang LT, et al. 2021. Molecules. 26:. PubMed
186. Singh N, et al. 2016. Dis Model Mech. 9: 885 - 897. PubMed
187. Cojohari O, Peppenelli M, Chan G 2016. Blood. 128: 529 - 541. PubMed

RRID

AB_1236488 (BioLegend Cat. No. 127605)
AB_1236494 (BioLegend Cat. No. 127606)

Antigen Details

Structure

A 21-35 kD GPI-anchorded membrane protein

Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type

Granulocytes, Macrophages, Monocytes

Biology Area

Immunology, Innate Immunity

Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID

546644 View all products for this Gene ID

UniProt

View information about Ly-6G on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis